换一批
换一批A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirine.
作者：
主题词
成年人(Adult);炔类(Alkynes);苯并恶嗪类(Benzoxazines);CD4淋巴细胞计数(CD4 Lymphocyte Count);中枢神经系统疾病(Central Nervous System Diseases);环丙烷类(Cyclopropanes);可行性研究(Feasibility Studies);HIV感染(HIV Infections);HIV蛋白酶抑制药(HIV Protease Inhibitors);HIV-1(HIV-1);人类(Humans);男(雄)性(Male);中年人(Middle Aged);腈类(Nitriles);试点项目(Pilot Projects);哒嗪类(Pyridazines);嘧啶类(Pyrimidines);RNA, 病毒(RNA, Viral);逆转录酶抑制剂(Reverse Transcriptase Inhibitors);入睡和睡眠障碍(Sleep Initiation and Maintenance Disorders);治疗结果(Treatment Outcome);病毒载量(Viral Load)
DOI
10.1097/QAD.0b013e328341685b
PMID
21099666
发布时间
2020-12-09
- 浏览32
AIDS (London, England)
65-71页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
